POLYDEX PHARMACEUTICALS LTD/BAHAMAS
10-Q, EX-27, 2000-06-13
PHARMACEUTICAL PREPARATIONS
Previous: POLYDEX PHARMACEUTICALS LTD/BAHAMAS, 10-Q, 2000-06-13
Next: PEOPLES BANCORP INC, 11-K, 2000-06-13



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JAN-31-2001
<PERIOD-START>                             FEB-01-2000
<PERIOD-END>                               APR-30-2000
<CASH>                                         456,323
<SECURITIES>                                         0
<RECEIVABLES>                                1,242,767
<ALLOWANCES>                                    16,969
<INVENTORY>                                  2,044,646
<CURRENT-ASSETS>                             3,812,854
<PP&E>                                      10,053,167
<DEPRECIATION>                               4,888,182
<TOTAL-ASSETS>                              11,692,459
<CURRENT-LIABILITIES>                        1,921,054
<BONDS>                                      1,119,246
                                0
                                     15,010
<COMMON>                                        50,245
<OTHER-SE>                                  23,132,553
<TOTAL-LIABILITY-AND-EQUITY>                11,692,459
<SALES>                                      3,392,829
<TOTAL-REVENUES>                             3,392,829
<CGS>                                        2,439,691
<TOTAL-COSTS>                                2,439,691
<OTHER-EXPENSES>                               688,891
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              74,646
<INCOME-PRETAX>                                201,006
<INCOME-TAX>                                   121,209
<INCOME-CONTINUING>                             79,797
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    79,797
<EPS-BASIC>                                       0.03
<EPS-DILUTED>                                     0.02


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission